GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Imaging Ltd (OTCPK:EMITF) » Definitions » EV-to-EBIT
中文

Elbit Imaging (Elbit Imaging) EV-to-EBIT : 0.41 (As of Apr. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Elbit Imaging EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Elbit Imaging's Enterprise Value is $-1.05 Mil. Elbit Imaging's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.56 Mil. Therefore, Elbit Imaging's EV-to-EBIT for today is 0.41.

The historical rank and industry rank for Elbit Imaging's EV-to-EBIT or its related term are showing as below:

EMITF' s EV-to-EBIT Range Over the Past 10 Years
Min: -288.58   Med: -14.07   Max: 0.85
Current: 0.41

During the past 13 years, the highest EV-to-EBIT of Elbit Imaging was 0.85. The lowest was -288.58. And the median was -14.07.

EMITF's EV-to-EBIT is ranked better than
95.27% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 19.86 vs EMITF: 0.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Elbit Imaging's Enterprise Value for the quarter that ended in Dec. 2023 was $0.18 Mil. Elbit Imaging's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.56 Mil. Elbit Imaging's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1,428.21%.


Elbit Imaging EV-to-EBIT Historical Data

The historical data trend for Elbit Imaging's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Imaging EV-to-EBIT Chart

Elbit Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.18 -12.32 -8.27 -4.66 -0.04

Elbit Imaging Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.27 - -4.66 - -0.04

Competitive Comparison of Elbit Imaging's EV-to-EBIT

For the Medical Devices subindustry, Elbit Imaging's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elbit Imaging's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elbit Imaging's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elbit Imaging's EV-to-EBIT falls into.



Elbit Imaging EV-to-EBIT Calculation

Elbit Imaging's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-1.054/-2.558
=0.41

Elbit Imaging's current Enterprise Value is $-1.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elbit Imaging's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Imaging  (OTCPK:EMITF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Elbit Imaging's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-2.558/0.179105
=-1,428.21 %

Elbit Imaging's Enterprise Value for the quarter that ended in Dec. 2023 was $0.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elbit Imaging's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Imaging EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Elbit Imaging's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Elbit Imaging (Elbit Imaging) Business Description

Traded in Other Exchanges
Address
3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102
Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.